| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthritis | 20 | 2024 | 666 | 4.270 |
Why?
|
| Neutrophils | 25 | 2023 | 3767 | 3.300 |
Why?
|
| Rheumatology | 18 | 2024 | 611 | 3.200 |
Why?
|
| Antirheumatic Agents | 22 | 2024 | 1374 | 2.530 |
Why?
|
| Megakaryocytes | 5 | 2022 | 565 | 2.450 |
Why?
|
| Adenosine Deaminase | 7 | 2023 | 251 | 2.340 |
Why?
|
| Arthritis, Rheumatoid | 24 | 2024 | 3763 | 2.330 |
Why?
|
| Macrophage Activation Syndrome | 9 | 2024 | 123 | 2.230 |
Why?
|
| Mast Cells | 14 | 2020 | 1390 | 2.190 |
Why?
|
| Immunoglobulin G | 17 | 2021 | 4541 | 2.160 |
Why?
|
| Arthritis, Experimental | 11 | 2021 | 291 | 2.120 |
Why?
|
| Synovial Membrane | 11 | 2024 | 524 | 2.080 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 9 | 2021 | 298 | 1.840 |
Why?
|
| Immunoglobulin Fc Fragments | 4 | 2021 | 280 | 1.830 |
Why?
|
| Antigens, Ly | 4 | 2019 | 292 | 1.760 |
Why?
|
| Lung Diseases | 6 | 2023 | 1915 | 1.580 |
Why?
|
| Emperipolesis | 3 | 2022 | 9 | 1.580 |
Why?
|
| Neutrophil Infiltration | 4 | 2019 | 393 | 1.300 |
Why?
|
| Glycosylation | 10 | 2021 | 1096 | 1.270 |
Why?
|
| Still's Disease, Adult-Onset | 2 | 2024 | 22 | 1.150 |
Why?
|
| Antigen-Antibody Complex | 6 | 2019 | 513 | 1.080 |
Why?
|
| Blood Platelets | 9 | 2022 | 2520 | 1.060 |
Why?
|
| Arthritis, Psoriatic | 5 | 2011 | 219 | 1.030 |
Why?
|
| Receptors, IgG | 8 | 2020 | 559 | 1.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 5 | 2023 | 1652 | 1.020 |
Why?
|
| Methotrexate | 8 | 2021 | 1719 | 1.020 |
Why?
|
| Lupus Erythematosus, Systemic | 8 | 2024 | 2159 | 1.010 |
Why?
|
| Uveitis | 7 | 2022 | 393 | 1.010 |
Why?
|
| Polymorphism, Single Nucleotide | 9 | 2024 | 15789 | 0.960 |
Why?
|
| Interleukin-1 | 9 | 2023 | 1249 | 0.920 |
Why?
|
| Glucocorticoids | 12 | 2024 | 2145 | 0.910 |
Why?
|
| Autoantibodies | 10 | 2023 | 2118 | 0.890 |
Why?
|
| Galactose | 2 | 2017 | 297 | 0.890 |
Why?
|
| Synovial Fluid | 12 | 2022 | 395 | 0.880 |
Why?
|
| Pleurisy | 2 | 2013 | 54 | 0.870 |
Why?
|
| I-kappa B Kinase | 1 | 2024 | 251 | 0.860 |
Why?
|
| Interleukins | 6 | 2019 | 785 | 0.850 |
Why?
|
| Interleukin-1beta | 6 | 2022 | 998 | 0.850 |
Why?
|
| Ikaros Transcription Factor | 1 | 2024 | 231 | 0.850 |
Why?
|
| Data Display | 1 | 2021 | 174 | 0.720 |
Why?
|
| Polysaccharides | 5 | 2021 | 1016 | 0.710 |
Why?
|
| Autoimmune Diseases | 7 | 2020 | 2250 | 0.700 |
Why?
|
| Interferon-alpha | 4 | 2021 | 918 | 0.680 |
Why?
|
| Receptors, Fc | 3 | 2021 | 534 | 0.650 |
Why?
|
| Inflammation | 14 | 2023 | 10756 | 0.640 |
Why?
|
| Receptors, Interleukin | 4 | 2014 | 243 | 0.630 |
Why?
|
| T-Lymphocytes, Regulatory | 4 | 2021 | 3075 | 0.630 |
Why?
|
| Cell Communication | 4 | 2022 | 1653 | 0.630 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 4 | 2024 | 264 | 0.620 |
Why?
|
| Joints | 7 | 2024 | 321 | 0.620 |
Why?
|
| Humans | 163 | 2024 | 760621 | 0.610 |
Why?
|
| Genetic Predisposition to Disease | 11 | 2024 | 17790 | 0.610 |
Why?
|
| Mentors | 4 | 2024 | 661 | 0.590 |
Why?
|
| Cytokines | 13 | 2023 | 7343 | 0.590 |
Why?
|
| Immune System Diseases | 2 | 2021 | 258 | 0.580 |
Why?
|
| Rheumatic Diseases | 4 | 2021 | 639 | 0.580 |
Why?
|
| Binding Sites, Antibody | 1 | 2017 | 337 | 0.580 |
Why?
|
| Inflammasomes | 3 | 2023 | 530 | 0.580 |
Why?
|
| Receptors, Cell Surface | 3 | 2017 | 2825 | 0.560 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2017 | 102 | 0.550 |
Why?
|
| Biological Therapy | 1 | 2018 | 139 | 0.550 |
Why?
|
| Agammaglobulinemia | 1 | 2018 | 173 | 0.550 |
Why?
|
| Pulmonary Alveoli | 1 | 2019 | 653 | 0.550 |
Why?
|
| Child | 56 | 2024 | 79806 | 0.550 |
Why?
|
| Temporomandibular Joint Disorders | 4 | 2022 | 220 | 0.550 |
Why?
|
| HLA Antigens | 2 | 2019 | 1368 | 0.550 |
Why?
|
| Receptors, CCR6 | 1 | 2016 | 73 | 0.540 |
Why?
|
| Editorial Policies | 1 | 2021 | 457 | 0.530 |
Why?
|
| Mice | 47 | 2024 | 81208 | 0.530 |
Why?
|
| Biological Products | 7 | 2023 | 916 | 0.520 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2018 | 226 | 0.520 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 5 | 2024 | 975 | 0.510 |
Why?
|
| Animals | 59 | 2024 | 167963 | 0.510 |
Why?
|
| Immunity, Humoral | 1 | 2019 | 604 | 0.500 |
Why?
|
| Dyspnea | 2 | 2013 | 1352 | 0.500 |
Why?
|
| Genome-Wide Association Study | 7 | 2024 | 12626 | 0.490 |
Why?
|
| Isoantigens | 1 | 2017 | 552 | 0.490 |
Why?
|
| Proto-Oncogene Proteins c-kit | 2 | 2017 | 727 | 0.490 |
Why?
|
| Monocytes | 4 | 2019 | 2575 | 0.470 |
Why?
|
| Toll-Like Receptors | 2 | 2019 | 590 | 0.470 |
Why?
|
| Estrogens | 2 | 2021 | 1520 | 0.460 |
Why?
|
| Peer Review, Research | 1 | 2017 | 340 | 0.450 |
Why?
|
| Terminology as Topic | 1 | 2021 | 1535 | 0.440 |
Why?
|
| Receptor, Anaphylatoxin C5a | 2 | 2010 | 87 | 0.440 |
Why?
|
| Th17 Cells | 1 | 2020 | 787 | 0.440 |
Why?
|
| Drug Hypersensitivity | 1 | 2022 | 916 | 0.430 |
Why?
|
| Publishing | 1 | 2020 | 836 | 0.430 |
Why?
|
| Chemokines | 1 | 2017 | 962 | 0.430 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2015 | 1446 | 0.420 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2020 | 1796 | 0.420 |
Why?
|
| Advisory Committees | 1 | 2017 | 788 | 0.410 |
Why?
|
| bcl-X Protein | 1 | 2014 | 413 | 0.410 |
Why?
|
| T-Lymphocytes | 4 | 2024 | 10181 | 0.410 |
Why?
|
| Biomedical Research | 4 | 2018 | 3426 | 0.400 |
Why?
|
| Child, Preschool | 28 | 2023 | 42063 | 0.400 |
Why?
|
| Research | 1 | 2020 | 1974 | 0.390 |
Why?
|
| Immunity, Innate | 4 | 2020 | 3047 | 0.380 |
Why?
|
| Mice, Knockout | 13 | 2021 | 14372 | 0.380 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 5 | 2023 | 537 | 0.370 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2018 | 1276 | 0.360 |
Why?
|
| Leukotriene B4 | 3 | 2023 | 280 | 0.360 |
Why?
|
| Receptors, Interferon | 2 | 2020 | 116 | 0.350 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 1484 | 0.350 |
Why?
|
| Periodicals as Topic | 2 | 2024 | 1469 | 0.350 |
Why?
|
| 5-Lipoxygenase-Activating Proteins | 2 | 2020 | 24 | 0.340 |
Why?
|
| Multigene Family | 1 | 2013 | 1077 | 0.340 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2023 | 4550 | 0.340 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2020 | 4357 | 0.340 |
Why?
|
| Sacroiliitis | 2 | 2019 | 9 | 0.340 |
Why?
|
| NF-kappa B | 4 | 2024 | 2488 | 0.330 |
Why?
|
| Leukotriene C4 | 2 | 2020 | 79 | 0.330 |
Why?
|
| Arachidonate 5-Lipoxygenase | 2 | 2020 | 128 | 0.320 |
Why?
|
| STAT1 Transcription Factor | 2 | 2021 | 333 | 0.320 |
Why?
|
| Computational Biology | 1 | 2021 | 3505 | 0.320 |
Why?
|
| Vasculitis | 3 | 2023 | 523 | 0.310 |
Why?
|
| Hematopoietic System | 1 | 2008 | 109 | 0.310 |
Why?
|
| Education, Medical, Continuing | 1 | 2014 | 830 | 0.310 |
Why?
|
| Male | 64 | 2024 | 359744 | 0.310 |
Why?
|
| Chromosome Inversion | 1 | 2008 | 120 | 0.300 |
Why?
|
| Adolescent | 30 | 2024 | 87810 | 0.300 |
Why?
|
| Phenotype | 10 | 2023 | 16546 | 0.300 |
Why?
|
| Lyme Disease | 3 | 2021 | 630 | 0.300 |
Why?
|
| Cell Polarity | 2 | 2021 | 638 | 0.290 |
Why?
|
| Lung | 4 | 2019 | 9994 | 0.290 |
Why?
|
| Female | 62 | 2024 | 391270 | 0.290 |
Why?
|
| Hemorrhage | 1 | 2019 | 3600 | 0.280 |
Why?
|
| Citrulline | 3 | 2016 | 106 | 0.280 |
Why?
|
| Interferons | 2 | 2020 | 705 | 0.280 |
Why?
|
| Systemic Inflammatory Response Syndrome | 2 | 2023 | 621 | 0.280 |
Why?
|
| Polymorphism, Genetic | 2 | 2016 | 4291 | 0.270 |
Why?
|
| Tryptases | 3 | 2015 | 176 | 0.270 |
Why?
|
| Alleles | 5 | 2024 | 6898 | 0.270 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2015 | 585 | 0.260 |
Why?
|
| Interinstitutional Relations | 2 | 2018 | 237 | 0.260 |
Why?
|
| Interferon-gamma | 3 | 2023 | 3157 | 0.260 |
Why?
|
| Consensus | 7 | 2019 | 3113 | 0.260 |
Why?
|
| Autoantigens | 5 | 2016 | 877 | 0.250 |
Why?
|
| Clinical Protocols | 3 | 2018 | 1440 | 0.250 |
Why?
|
| Blood Sedimentation | 2 | 2019 | 234 | 0.240 |
Why?
|
| B-Lymphocytes | 4 | 2024 | 4742 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 18 | 2021 | 22023 | 0.230 |
Why?
|
| Flow Cytometry | 7 | 2019 | 5870 | 0.220 |
Why?
|
| Serine Endopeptidases | 1 | 2008 | 1021 | 0.220 |
Why?
|
| Jurkat Cells | 3 | 2021 | 736 | 0.210 |
Why?
|
| Temporomandibular Joint | 3 | 2022 | 196 | 0.210 |
Why?
|
| Hereditary Autoinflammatory Diseases | 1 | 2023 | 42 | 0.210 |
Why?
|
| Reactive Oxygen Species | 4 | 2019 | 2138 | 0.210 |
Why?
|
| Raynaud Disease | 1 | 2003 | 79 | 0.200 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3085 | 0.200 |
Why?
|
| Adult | 27 | 2024 | 219994 | 0.200 |
Why?
|
| Dendritic Cells | 1 | 2013 | 2725 | 0.200 |
Why?
|
| Osteoclasts | 3 | 2021 | 711 | 0.200 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3205 | 0.200 |
Why?
|
| Program Evaluation | 2 | 2024 | 2493 | 0.200 |
Why?
|
| Estradiol | 2 | 2021 | 1932 | 0.200 |
Why?
|
| Cell Movement | 4 | 2019 | 5206 | 0.190 |
Why?
|
| Fibroblasts | 6 | 2018 | 4090 | 0.190 |
Why?
|
| Immunologic Factors | 2 | 2019 | 1588 | 0.190 |
Why?
|
| Disease Progression | 5 | 2024 | 13502 | 0.190 |
Why?
|
| Respiratory System | 1 | 2024 | 557 | 0.190 |
Why?
|
| Synovitis | 2 | 2016 | 215 | 0.190 |
Why?
|
| Glucose-6-Phosphate Isomerase | 2 | 2015 | 50 | 0.190 |
Why?
|
| C-Reactive Protein | 4 | 2022 | 3839 | 0.190 |
Why?
|
| Coronary Aneurysm | 1 | 2023 | 233 | 0.190 |
Why?
|
| Single-Cell Analysis | 3 | 2021 | 2380 | 0.180 |
Why?
|
| Occupational Therapy | 2 | 2019 | 139 | 0.180 |
Why?
|
| Cell-Derived Microparticles | 2 | 2015 | 161 | 0.180 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2020 | 376 | 0.180 |
Why?
|
| Sequence Analysis, RNA | 4 | 2021 | 2005 | 0.180 |
Why?
|
| Cells, Cultured | 11 | 2021 | 18957 | 0.180 |
Why?
|
| Chemotaxis | 1 | 2023 | 598 | 0.180 |
Why?
|
| Peritonitis | 2 | 2021 | 369 | 0.180 |
Why?
|
| Prevotella | 1 | 2020 | 80 | 0.180 |
Why?
|
| Dioxygenases | 1 | 2022 | 335 | 0.170 |
Why?
|
| Immunosuppressive Agents | 3 | 2019 | 4166 | 0.170 |
Why?
|
| Tarsus, Animal | 1 | 2019 | 5 | 0.170 |
Why?
|
| RANK Ligand | 1 | 2021 | 318 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-maf | 1 | 2019 | 69 | 0.170 |
Why?
|
| Interferon Type I | 1 | 2023 | 559 | 0.170 |
Why?
|
| Borrelia burgdorferi | 1 | 2021 | 183 | 0.170 |
Why?
|
| Chemokine CXCL9 | 1 | 2019 | 135 | 0.170 |
Why?
|
| Polyarteritis Nodosa | 1 | 2020 | 70 | 0.170 |
Why?
|
| Pediatrics | 3 | 2024 | 3586 | 0.170 |
Why?
|
| STAT5 Transcription Factor | 1 | 2020 | 264 | 0.170 |
Why?
|
| Infant | 11 | 2021 | 36060 | 0.160 |
Why?
|
| Adoptive Transfer | 1 | 2021 | 822 | 0.160 |
Why?
|
| Macrophages | 4 | 2021 | 5745 | 0.160 |
Why?
|
| Proteoglycans | 2 | 2015 | 801 | 0.160 |
Why?
|
| Genetic Loci | 5 | 2021 | 2618 | 0.160 |
Why?
|
| Macrophages, Peritoneal | 1 | 2019 | 237 | 0.160 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2024 | 727 | 0.160 |
Why?
|
| Tuberculosis | 3 | 2019 | 2001 | 0.160 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2023 | 538 | 0.160 |
Why?
|
| Physical Therapy Modalities | 2 | 2019 | 536 | 0.160 |
Why?
|
| src-Family Kinases | 2 | 2020 | 535 | 0.160 |
Why?
|
| Interleukin-10 | 2 | 2021 | 1175 | 0.160 |
Why?
|
| Mice, Transgenic | 9 | 2020 | 9530 | 0.160 |
Why?
|
| Eosinophilia | 1 | 2023 | 559 | 0.150 |
Why?
|
| Heart Defects, Congenital | 2 | 2020 | 4673 | 0.150 |
Why?
|
| Platelet Membrane Glycoproteins | 2 | 2017 | 285 | 0.150 |
Why?
|
| Disease Models, Animal | 7 | 2019 | 18137 | 0.150 |
Why?
|
| Interleukin-18 | 1 | 2019 | 251 | 0.150 |
Why?
|
| Antigens, Bacterial | 2 | 2021 | 1155 | 0.150 |
Why?
|
| Mice, Inbred BALB C | 4 | 2021 | 6216 | 0.150 |
Why?
|
| Nuclear Envelope | 1 | 2019 | 163 | 0.150 |
Why?
|
| Serpins | 1 | 2019 | 247 | 0.150 |
Why?
|
| NF-E2 Transcription Factor, p45 Subunit | 1 | 2017 | 53 | 0.150 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2021 | 1827 | 0.140 |
Why?
|
| Osteogenesis | 2 | 2021 | 1271 | 0.140 |
Why?
|
| Pasteurellaceae Infections | 1 | 2016 | 3 | 0.140 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2018 | 261 | 0.140 |
Why?
|
| Immunologic Memory | 1 | 2024 | 1354 | 0.140 |
Why?
|
| Mycobacterium Infections | 1 | 2017 | 121 | 0.140 |
Why?
|
| Spondylarthritis | 1 | 2018 | 58 | 0.140 |
Why?
|
| Diagnosis, Differential | 8 | 2019 | 12965 | 0.140 |
Why?
|
| Endemic Diseases | 2 | 2018 | 190 | 0.140 |
Why?
|
| Cell Separation | 2 | 2019 | 1720 | 0.140 |
Why?
|
| Ferritins | 1 | 2019 | 597 | 0.140 |
Why?
|
| Leukocytosis | 2 | 2018 | 251 | 0.140 |
Why?
|
| Fertility Agents, Female | 1 | 2017 | 101 | 0.140 |
Why?
|
| Immunomodulation | 1 | 2020 | 547 | 0.140 |
Why?
|
| Goserelin | 1 | 2017 | 127 | 0.140 |
Why?
|
| Basophils | 1 | 2019 | 404 | 0.140 |
Why?
|
| Dermatomyositis | 1 | 2019 | 256 | 0.140 |
Why?
|
| Leukocyte Count | 2 | 2018 | 1600 | 0.140 |
Why?
|
| Cell Differentiation | 4 | 2021 | 11481 | 0.140 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2001 | 601 | 0.140 |
Why?
|
| STAT3 Transcription Factor | 1 | 2021 | 877 | 0.140 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2017 | 132 | 0.130 |
Why?
|
| Physical Examination | 1 | 2022 | 1244 | 0.130 |
Why?
|
| Endosomes | 1 | 2019 | 519 | 0.130 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2016 | 31 | 0.130 |
Why?
|
| Cytoplasm | 2 | 2019 | 1516 | 0.130 |
Why?
|
| Rheumatoid Factor | 1 | 2016 | 185 | 0.130 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2020 | 664 | 0.130 |
Why?
|
| Endothelium | 1 | 2018 | 764 | 0.130 |
Why?
|
| GPI-Linked Proteins | 1 | 2017 | 468 | 0.130 |
Why?
|
| Capillary Permeability | 2 | 2012 | 768 | 0.130 |
Why?
|
| Receptors, Mitogen | 1 | 2015 | 61 | 0.130 |
Why?
|
| Fullerenes | 1 | 2015 | 14 | 0.130 |
Why?
|
| Phosphorylation | 4 | 2021 | 8313 | 0.130 |
Why?
|
| HCT116 Cells | 1 | 2016 | 402 | 0.130 |
Why?
|
| Toe Joint | 1 | 2015 | 19 | 0.130 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2017 | 275 | 0.130 |
Why?
|
| Bone Remodeling | 1 | 2019 | 580 | 0.130 |
Why?
|
| Heart | 1 | 2008 | 4393 | 0.130 |
Why?
|
| Registries | 5 | 2018 | 8469 | 0.120 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2019 | 1126 | 0.120 |
Why?
|
| Gout | 1 | 2022 | 620 | 0.120 |
Why?
|
| Leuprolide | 1 | 2017 | 315 | 0.120 |
Why?
|
| Phospholipases A2, Secretory | 1 | 2015 | 30 | 0.120 |
Why?
|
| Bone Marrow Cells | 2 | 2021 | 2414 | 0.120 |
Why?
|
| Interleukin-6 | 2 | 2022 | 3215 | 0.120 |
Why?
|
| Signal Transduction | 8 | 2023 | 23376 | 0.120 |
Why?
|
| Group II Phospholipases A2 | 1 | 2014 | 12 | 0.120 |
Why?
|
| Drug Approval | 1 | 2022 | 816 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2020 | 1869 | 0.120 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 616 | 0.120 |
Why?
|
| High-Throughput Screening Assays | 2 | 2018 | 944 | 0.120 |
Why?
|
| Immunoglobulin Constant Regions | 1 | 2014 | 58 | 0.120 |
Why?
|
| Platelet Activation | 3 | 2014 | 660 | 0.120 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2019 | 1245 | 0.120 |
Why?
|
| Age of Onset | 3 | 2024 | 3301 | 0.120 |
Why?
|
| Fontan Procedure | 1 | 2020 | 791 | 0.120 |
Why?
|
| Finger Joint | 1 | 2015 | 108 | 0.120 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2018 | 488 | 0.120 |
Why?
|
| Arthritis, Infectious | 2 | 2018 | 345 | 0.120 |
Why?
|
| Case-Control Studies | 11 | 2021 | 22053 | 0.120 |
Why?
|
| Frozen Sections | 1 | 2015 | 153 | 0.120 |
Why?
|
| Point Mutation | 2 | 2014 | 1594 | 0.110 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2014 | 48 | 0.110 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2019 | 828 | 0.110 |
Why?
|
| Paraffin Embedding | 1 | 2015 | 302 | 0.110 |
Why?
|
| Major Histocompatibility Complex | 1 | 2016 | 928 | 0.110 |
Why?
|
| Peptides, Cyclic | 1 | 2016 | 392 | 0.110 |
Why?
|
| Interferon-beta | 1 | 2015 | 345 | 0.110 |
Why?
|
| Helminthiasis | 1 | 2014 | 80 | 0.110 |
Why?
|
| Cytoskeletal Proteins | 1 | 2019 | 1343 | 0.110 |
Why?
|
| Membrane Transport Proteins | 1 | 2019 | 1035 | 0.110 |
Why?
|
| Cartilage Diseases | 1 | 2015 | 156 | 0.110 |
Why?
|
| Research Personnel | 1 | 2018 | 582 | 0.110 |
Why?
|
| Aromatase Inhibitors | 1 | 2017 | 511 | 0.110 |
Why?
|
| Gene Order | 1 | 2013 | 169 | 0.110 |
Why?
|
| Longitudinal Studies | 4 | 2024 | 14495 | 0.110 |
Why?
|
| Pilot Projects | 4 | 2022 | 8555 | 0.110 |
Why?
|
| Zebrafish Proteins | 1 | 2019 | 1006 | 0.110 |
Why?
|
| Antibodies, Bacterial | 2 | 2021 | 1468 | 0.100 |
Why?
|
| Premenopause | 1 | 2017 | 1038 | 0.100 |
Why?
|
| Comparative Effectiveness Research | 1 | 2018 | 718 | 0.100 |
Why?
|
| Treatment Outcome | 11 | 2023 | 65017 | 0.100 |
Why?
|
| Ophthalmology | 1 | 2019 | 549 | 0.100 |
Why?
|
| Disease Management | 2 | 2014 | 2514 | 0.100 |
Why?
|
| ras Guanine Nucleotide Exchange Factors | 1 | 2012 | 34 | 0.100 |
Why?
|
| HIV Antigens | 1 | 2013 | 325 | 0.100 |
Why?
|
| Reference Values | 1 | 2019 | 4925 | 0.100 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2019 | 2282 | 0.100 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2014 | 440 | 0.100 |
Why?
|
| Leukocytes | 2 | 2017 | 2026 | 0.100 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 2012 | 92 | 0.100 |
Why?
|
| Lectins, C-Type | 1 | 2015 | 587 | 0.100 |
Why?
|
| Syndrome | 2 | 2013 | 3280 | 0.100 |
Why?
|
| Sensitivity and Specificity | 4 | 2021 | 14660 | 0.100 |
Why?
|
| Gene Expression Regulation | 4 | 2024 | 11903 | 0.100 |
Why?
|
| Needs Assessment | 1 | 2018 | 1139 | 0.100 |
Why?
|
| Periodontitis | 1 | 2016 | 560 | 0.100 |
Why?
|
| Societies, Medical | 2 | 2014 | 3905 | 0.100 |
Why?
|
| Neutrophil Activation | 1 | 2012 | 181 | 0.100 |
Why?
|
| Lymphocytes | 1 | 2019 | 2611 | 0.100 |
Why?
|
| Cell Line | 4 | 2021 | 15620 | 0.100 |
Why?
|
| Hip Joint | 1 | 2018 | 1006 | 0.090 |
Why?
|
| Feces | 1 | 2018 | 1455 | 0.090 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 1791 | 0.090 |
Why?
|
| Quality Improvement | 2 | 2024 | 3836 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2018 | 3455 | 0.090 |
Why?
|
| Peritoneum | 1 | 2012 | 224 | 0.090 |
Why?
|
| Microspheres | 1 | 2014 | 787 | 0.090 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2017 | 1153 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 3804 | 0.090 |
Why?
|
| Stem Cell Transplantation | 1 | 2019 | 1599 | 0.090 |
Why?
|
| Histones | 1 | 2021 | 2583 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2021 | 4353 | 0.090 |
Why?
|
| Staining and Labeling | 1 | 2015 | 1089 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 2471 | 0.090 |
Why?
|
| Cluster Analysis | 3 | 2019 | 2698 | 0.090 |
Why?
|
| Antibodies | 2 | 2023 | 2421 | 0.090 |
Why?
|
| Knee Joint | 2 | 2021 | 1663 | 0.090 |
Why?
|
| Feedback, Physiological | 1 | 2012 | 476 | 0.090 |
Why?
|
| Nanostructures | 1 | 2015 | 547 | 0.090 |
Why?
|
| Mass Screening | 3 | 2019 | 5423 | 0.090 |
Why?
|
| Pneumonia | 2 | 2021 | 2131 | 0.090 |
Why?
|
| Bayes Theorem | 1 | 2018 | 2326 | 0.090 |
Why?
|
| Sex Factors | 2 | 2017 | 10547 | 0.080 |
Why?
|
| Extracellular Matrix | 2 | 2015 | 1726 | 0.080 |
Why?
|
| Androgens | 1 | 2017 | 1291 | 0.080 |
Why?
|
| Fibrinogen | 1 | 2012 | 886 | 0.080 |
Why?
|
| Spleen | 2 | 2021 | 2298 | 0.080 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2010 | 377 | 0.080 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2019 | 1903 | 0.080 |
Why?
|
| Receptors, CXCR5 | 2 | 2019 | 88 | 0.080 |
Why?
|
| Chronic Disease | 3 | 2016 | 9287 | 0.080 |
Why?
|
| Cyclooxygenase 1 | 1 | 2008 | 97 | 0.080 |
Why?
|
| Immunocompromised Host | 1 | 2013 | 857 | 0.080 |
Why?
|
| Predictive Value of Tests | 5 | 2019 | 15289 | 0.080 |
Why?
|
| Choice Behavior | 1 | 2014 | 821 | 0.080 |
Why?
|
| Risk Factors | 9 | 2024 | 74359 | 0.080 |
Why?
|
| Respiratory Function Tests | 1 | 2013 | 1683 | 0.080 |
Why?
|
| Inflammation Mediators | 2 | 2009 | 1881 | 0.080 |
Why?
|
| Receptors, IgE | 2 | 2020 | 372 | 0.080 |
Why?
|
| Postmenopause | 1 | 2017 | 2509 | 0.070 |
Why?
|
| Zebrafish | 1 | 2019 | 2997 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 3758 | 0.070 |
Why?
|
| Immunization | 2 | 2022 | 1227 | 0.070 |
Why?
|
| Blood Proteins | 1 | 2012 | 1173 | 0.070 |
Why?
|
| Gene Knockout Techniques | 2 | 2021 | 802 | 0.070 |
Why?
|
| Patients | 1 | 2014 | 906 | 0.070 |
Why?
|
| Prostaglandins | 1 | 2008 | 398 | 0.070 |
Why?
|
| Age Factors | 5 | 2018 | 18416 | 0.070 |
Why?
|
| Complement Membrane Attack Complex | 2 | 2019 | 105 | 0.070 |
Why?
|
| Immune Tolerance | 1 | 2016 | 2299 | 0.070 |
Why?
|
| Health Care Surveys | 1 | 2014 | 2435 | 0.070 |
Why?
|
| HIV Antibodies | 1 | 2013 | 1300 | 0.070 |
Why?
|
| Thrombocytosis | 1 | 2006 | 82 | 0.070 |
Why?
|
| Testosterone | 1 | 2017 | 2470 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 3800 | 0.070 |
Why?
|
| Transcription, Genetic | 2 | 2017 | 7593 | 0.070 |
Why?
|
| Graft Rejection | 1 | 2019 | 4426 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2019 | 4938 | 0.060 |
Why?
|
| United States | 9 | 2024 | 72461 | 0.060 |
Why?
|
| Immunoglobulin E | 2 | 2019 | 1484 | 0.060 |
Why?
|
| Cell Lineage | 1 | 2015 | 2533 | 0.060 |
Why?
|
| Pain Measurement | 3 | 2022 | 3528 | 0.060 |
Why?
|
| Cyclooxygenase 2 | 1 | 2008 | 599 | 0.060 |
Why?
|
| Interleukin-17 | 2 | 2023 | 910 | 0.060 |
Why?
|
| Education, Medical, Graduate | 1 | 2018 | 2363 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 1173 | 0.060 |
Why?
|
| Canada | 2 | 2024 | 2128 | 0.060 |
Why?
|
| Drug Therapy, Combination | 2 | 2017 | 6498 | 0.060 |
Why?
|
| Intestines | 1 | 2014 | 1907 | 0.060 |
Why?
|
| Antibodies, Antinuclear | 1 | 2006 | 344 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 16939 | 0.060 |
Why?
|
| Developmental Disabilities | 1 | 2014 | 1504 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2012 | 2913 | 0.060 |
Why?
|
| Feasibility Studies | 3 | 2024 | 5201 | 0.060 |
Why?
|
| Retrospective Studies | 11 | 2024 | 80372 | 0.060 |
Why?
|
| International Cooperation | 1 | 2011 | 1433 | 0.060 |
Why?
|
| Autoimmunity | 1 | 2012 | 1370 | 0.060 |
Why?
|
| Membrane Glycoproteins | 1 | 2015 | 3707 | 0.060 |
Why?
|
| Cell Survival | 1 | 2014 | 5797 | 0.060 |
Why?
|
| Middle Aged | 10 | 2021 | 220352 | 0.060 |
Why?
|
| Activities of Daily Living | 1 | 2013 | 2417 | 0.060 |
Why?
|
| Immune System | 2 | 2024 | 798 | 0.060 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 2315 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4573 | 0.050 |
Why?
|
| Quality of Life | 5 | 2022 | 13308 | 0.050 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 3022 | 0.050 |
Why?
|
| Pain | 2 | 2021 | 5066 | 0.050 |
Why?
|
| Gene Expression Profiling | 5 | 2019 | 9411 | 0.050 |
Why?
|
| Interleukin-15 | 1 | 2023 | 183 | 0.050 |
Why?
|
| Aging | 1 | 2022 | 8651 | 0.050 |
Why?
|
| Genotype | 4 | 2020 | 12960 | 0.050 |
Why?
|
| Eicosanoids | 1 | 2004 | 278 | 0.050 |
Why?
|
| Mutation | 4 | 2023 | 29932 | 0.050 |
Why?
|
| Capillaries | 1 | 2006 | 744 | 0.050 |
Why?
|
| Apoptosis | 3 | 2015 | 9501 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2004 | 616 | 0.050 |
Why?
|
| Cytoplasmic Granules | 1 | 2004 | 573 | 0.050 |
Why?
|
| HLA-DR Antigens | 1 | 2023 | 630 | 0.050 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2006 | 368 | 0.050 |
Why?
|
| Radiography | 1 | 2013 | 6965 | 0.050 |
Why?
|
| Coculture Techniques | 2 | 2019 | 1342 | 0.050 |
Why?
|
| Cathepsin G | 1 | 2021 | 31 | 0.050 |
Why?
|
| Cell Nucleus | 2 | 2021 | 2907 | 0.050 |
Why?
|
| Mesoderm | 1 | 2004 | 672 | 0.050 |
Why?
|
| Collagen | 1 | 2010 | 2636 | 0.050 |
Why?
|
| Heparin | 1 | 2009 | 1652 | 0.050 |
Why?
|
| Oxidation-Reduction | 2 | 2019 | 2222 | 0.050 |
Why?
|
| Mitochondria | 1 | 2014 | 3600 | 0.050 |
Why?
|
| Fever of Unknown Origin | 1 | 2001 | 94 | 0.050 |
Why?
|
| Myeloblastin | 1 | 2021 | 101 | 0.050 |
Why?
|
| Quassins | 1 | 2020 | 6 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2006 | 1955 | 0.050 |
Why?
|
| Coronary Vessels | 2 | 2019 | 3112 | 0.050 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2002 | 102 | 0.050 |
Why?
|
| Oleanolic Acid | 1 | 2020 | 42 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2020 | 110 | 0.040 |
Why?
|
| Leukocyte Elastase | 1 | 2021 | 114 | 0.040 |
Why?
|
| Particle Size | 2 | 2016 | 1644 | 0.040 |
Why?
|
| Enzyme Assays | 1 | 2021 | 107 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2001 | 257 | 0.040 |
Why?
|
| Red-Cell Aplasia, Pure | 1 | 2020 | 27 | 0.040 |
Why?
|
| Musculoskeletal Diseases | 1 | 2006 | 595 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 9185 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 8624 | 0.040 |
Why?
|
| Parents | 1 | 2014 | 3549 | 0.040 |
Why?
|
| Quantitative Trait Loci | 2 | 2018 | 2101 | 0.040 |
Why?
|
| Fever | 2 | 2023 | 1617 | 0.040 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 2019 | 48 | 0.040 |
Why?
|
| Cell Degranulation | 1 | 2020 | 276 | 0.040 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2019 | 112 | 0.040 |
Why?
|
| Serologic Tests | 1 | 2021 | 383 | 0.040 |
Why?
|
| Proteomics | 2 | 2023 | 3817 | 0.040 |
Why?
|
| Gene Frequency | 2 | 2018 | 3615 | 0.040 |
Why?
|
| Mammals | 1 | 2024 | 1131 | 0.040 |
Why?
|
| Calcium | 1 | 2012 | 5725 | 0.040 |
Why?
|
| Pregnancy | 1 | 2021 | 29749 | 0.040 |
Why?
|
| Ascites | 1 | 2020 | 338 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2021 | 4264 | 0.040 |
Why?
|
| Algorithms | 4 | 2021 | 13981 | 0.040 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2019 | 144 | 0.040 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 418 | 0.040 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2019 | 202 | 0.040 |
Why?
|
| Fathers | 1 | 2001 | 376 | 0.040 |
Why?
|
| Serum | 1 | 2019 | 211 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2019 | 2873 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2013 | 3204 | 0.040 |
Why?
|
| Injections, Intra-Articular | 1 | 2019 | 279 | 0.040 |
Why?
|
| Chromosome Mapping | 2 | 2018 | 4625 | 0.040 |
Why?
|
| Phagocytes | 1 | 2019 | 296 | 0.040 |
Why?
|
| Janus Kinase 1 | 1 | 2017 | 107 | 0.040 |
Why?
|
| Macrophage-Activating Factors | 1 | 2017 | 21 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2012 | 12766 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2020 | 554 | 0.040 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2012 | 2421 | 0.040 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2021 | 701 | 0.040 |
Why?
|
| High Mobility Group Proteins | 1 | 2017 | 176 | 0.040 |
Why?
|
| Gene Expression | 2 | 2020 | 7588 | 0.040 |
Why?
|
| Chemokine CXCL13 | 1 | 2017 | 59 | 0.040 |
Why?
|
| T-Box Domain Proteins | 1 | 2019 | 468 | 0.030 |
Why?
|
| Respiratory Tract Infections | 1 | 2024 | 1007 | 0.030 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2019 | 477 | 0.030 |
Why?
|
| Immunoglobulin A | 1 | 2020 | 979 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2021 | 1871 | 0.030 |
Why?
|
| Exanthema | 1 | 2001 | 504 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2017 | 191 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2021 | 1032 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 2021 | 1529 | 0.030 |
Why?
|
| Peru | 1 | 2019 | 869 | 0.030 |
Why?
|
| Erythrocytes | 2 | 2016 | 2415 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 2004 | 1403 | 0.030 |
Why?
|
| Uric Acid | 1 | 2022 | 806 | 0.030 |
Why?
|
| Repressor Proteins | 2 | 2017 | 2981 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 5397 | 0.030 |
Why?
|
| Young Adult | 6 | 2021 | 58741 | 0.030 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2017 | 305 | 0.030 |
Why?
|
| Genetic Variation | 2 | 2021 | 6551 | 0.030 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2017 | 306 | 0.030 |
Why?
|
| Stem Cells | 1 | 2008 | 3523 | 0.030 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2015 | 68 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2004 | 2536 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2018 | 41335 | 0.030 |
Why?
|
| Epigenomics | 1 | 2021 | 936 | 0.030 |
Why?
|
| Bone Resorption | 1 | 2019 | 720 | 0.030 |
Why?
|
| Cathepsin B | 1 | 2015 | 80 | 0.030 |
Why?
|
| Rickettsia prowazekii | 1 | 2014 | 1 | 0.030 |
Why?
|
| Cephalometry | 1 | 2016 | 382 | 0.030 |
Why?
|
| Genitalia, Male | 1 | 2015 | 87 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 15840 | 0.030 |
Why?
|
| Microscopy | 1 | 2020 | 885 | 0.030 |
Why?
|
| Serotonin | 2 | 2012 | 1040 | 0.030 |
Why?
|
| Protein Binding | 2 | 2019 | 9335 | 0.030 |
Why?
|
| Clinical Trials as Topic | 2 | 2023 | 8056 | 0.030 |
Why?
|
| Imidazoles | 1 | 2020 | 1180 | 0.030 |
Why?
|
| Myocarditis | 1 | 2002 | 766 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2004 | 2640 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 2015 | 622 | 0.030 |
Why?
|
| Ketones | 1 | 2015 | 183 | 0.030 |
Why?
|
| Thrombin | 1 | 2016 | 593 | 0.030 |
Why?
|
| Cell Count | 1 | 2018 | 1835 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2019 | 2627 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2015 | 296 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2018 | 1006 | 0.030 |
Why?
|
| Receptors, Chemokine | 1 | 2017 | 655 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2015 | 665 | 0.030 |
Why?
|
| Species Specificity | 1 | 2018 | 2418 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 36290 | 0.030 |
Why?
|
| Receptors, CCR | 1 | 2013 | 37 | 0.030 |
Why?
|
| Cadherins | 1 | 2018 | 898 | 0.030 |
Why?
|
| Wrist Joint | 1 | 2015 | 265 | 0.030 |
Why?
|
| Dipeptides | 1 | 2015 | 409 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2001 | 1841 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2018 | 1456 | 0.030 |
Why?
|
| Anaphylaxis | 1 | 2020 | 755 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2001 | 4107 | 0.030 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2016 | 471 | 0.030 |
Why?
|
| Granzymes | 1 | 2013 | 276 | 0.020 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2012 | 97 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2019 | 1664 | 0.020 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2020 | 1717 | 0.020 |
Why?
|
| Peptide Library | 1 | 2013 | 347 | 0.020 |
Why?
|
| Complement Activation | 1 | 2013 | 446 | 0.020 |
Why?
|
| Gadolinium | 1 | 2016 | 959 | 0.020 |
Why?
|
| Program Development | 1 | 2018 | 1297 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2017 | 979 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2021 | 6538 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2023 | 4219 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2017 | 2648 | 0.020 |
Why?
|
| Ankle Joint | 1 | 2015 | 435 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2012 | 818 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2013 | 1060 | 0.020 |
Why?
|
| Body Size | 1 | 2014 | 462 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2012 | 508 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2015 | 1837 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2001 | 4000 | 0.020 |
Why?
|
| Molecular Sequence Annotation | 1 | 2013 | 524 | 0.020 |
Why?
|
| Gap Junctions | 1 | 2012 | 230 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2022 | 3562 | 0.020 |
Why?
|
| Amino Acids | 1 | 2016 | 1714 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2018 | 1500 | 0.020 |
Why?
|
| Aged | 4 | 2021 | 169152 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 7475 | 0.020 |
Why?
|
| Oligosaccharides | 1 | 2012 | 405 | 0.020 |
Why?
|
| Receptors, Collagen | 1 | 2010 | 25 | 0.020 |
Why?
|
| Myeloid Cells | 1 | 2015 | 820 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2019 | 6068 | 0.020 |
Why?
|
| Cross-Sectional Studies | 3 | 2016 | 25942 | 0.020 |
Why?
|
| Incidence | 2 | 2023 | 21392 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2020 | 2802 | 0.020 |
Why?
|
| Carcinogens | 1 | 2012 | 449 | 0.020 |
Why?
|
| Interleukin-1alpha | 1 | 2010 | 86 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 1889 | 0.020 |
Why?
|
| Chromatin | 1 | 2021 | 2938 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2013 | 13451 | 0.020 |
Why?
|
| DNA, Mitochondrial | 1 | 2014 | 858 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 1544 | 0.020 |
Why?
|
| Leukotrienes | 1 | 2010 | 231 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 5496 | 0.020 |
Why?
|
| North America | 1 | 2012 | 1284 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2019 | 2560 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2013 | 1697 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 17624 | 0.020 |
Why?
|
| Sulfotransferases | 1 | 2009 | 149 | 0.020 |
Why?
|
| Homeostasis | 1 | 2019 | 3306 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2016 | 1810 | 0.020 |
Why?
|
| Base Sequence | 1 | 2019 | 12446 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2013 | 1996 | 0.020 |
Why?
|
| Amidohydrolases | 1 | 2009 | 162 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2015 | 5039 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2020 | 2275 | 0.020 |
Why?
|
| Fellowships and Scholarships | 1 | 2016 | 1116 | 0.020 |
Why?
|
| DNA | 1 | 2001 | 7233 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2018 | 2963 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2021 | 4373 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2014 | 3094 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 2895 | 0.020 |
Why?
|
| Bacteria | 1 | 2018 | 2199 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 3696 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2018 | 4713 | 0.020 |
Why?
|
| Research Design | 1 | 2022 | 6180 | 0.020 |
Why?
|
| HIV Infections | 1 | 2013 | 17165 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2006 | 6659 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 2192 | 0.020 |
Why?
|
| Benchmarking | 1 | 2012 | 1044 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2015 | 3682 | 0.020 |
Why?
|
| Virus Replication | 1 | 2013 | 2432 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 9585 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2012 | 2208 | 0.020 |
Why?
|
| Curriculum | 1 | 2018 | 3718 | 0.010 |
Why?
|
| Histamine | 1 | 2006 | 498 | 0.010 |
Why?
|
| Dilatation, Pathologic | 1 | 2005 | 527 | 0.010 |
Why?
|
| Platelet Count | 1 | 2006 | 777 | 0.010 |
Why?
|
| Contrast Media | 1 | 2016 | 5305 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 58995 | 0.010 |
Why?
|
| Ligands | 1 | 2010 | 3276 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 2006 | 987 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2012 | 4122 | 0.010 |
Why?
|
| Data Collection | 1 | 2012 | 3315 | 0.010 |
Why?
|
| Rats | 1 | 2019 | 23711 | 0.010 |
Why?
|
| Proteins | 1 | 2017 | 6029 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2017 | 54303 | 0.010 |
Why?
|
| Self Report | 1 | 2014 | 3711 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2019 | 7850 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2014 | 4433 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2010 | 2693 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2015 | 3539 | 0.010 |
Why?
|
| Giant Cells | 1 | 2002 | 185 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 10344 | 0.010 |
Why?
|
| Boston | 1 | 2014 | 9280 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2015 | 8035 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 1972 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 20080 | 0.010 |
Why?
|
| Physicians | 1 | 2016 | 4591 | 0.010 |
Why?
|
| Comorbidity | 1 | 2011 | 10551 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 11071 | 0.010 |
Why?
|
| Prognosis | 1 | 2015 | 29658 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2014 | 7818 | 0.010 |
Why?
|
| Asthma | 1 | 2012 | 6172 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2006 | 5961 | 0.010 |
Why?
|
| Echocardiography | 1 | 2005 | 4981 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39261 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2002 | 3224 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2006 | 26181 | 0.000 |
Why?
|